首页> 美国卫生研究院文献>other >Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality
【2h】

Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality

机译:儿科异基因HCT之前血清白蛋白水平低与对重症监护干预的需求增加以及6个月死亡率增加有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poor nutritional status in HCT patients is a negative prognostic factor. There are no pediatric studies evaluating albumin levels prior to HCT and need for critical care interventions. We hypothesized that pediatric patients with low albumin levels, routinely measured 30 days (±10 days) prior to allogeneic HCT, have a higher risk of critical care interventions in the post-transplant period. We performed a 5-year retrospective study of pediatric patients who underwent allogeneic HCT for any indication. Patients were categorized based on albumin level. Hypoalbuminemia was defined as <3.1 g/dL. A total of 73 patients were included, with a median age of 7.4 years (IQR 3.3, 13.2). Patients with hypoalbuminemia had higher needs for critical care interventions including non-invasive ventilation (44% vs 8%, P=.01), mechanical ventilation (67% vs 17%, P<.01), and vasoactive therapy (56% vs 16%, P=.01). Patients with hypoalbuminemia also had a higher 6-month mortality (56% vs 17%, P=.02). Our data demonstrate that children undergoing allogeneic HCT with hypoalbuminemia in the pretransplant period are more likely to require critical care interventions and have higher 6-month mortality. These findings identify an at-risk population in which nutritional improvements may be instituted prior to HCT in hopes of improving outcomes.
机译:HCT患者营养状况差是预后不良。尚无儿科研究评估HCT之前的白蛋白水平以及是否需要重症监护干预措施。我们假设同种异体HCT之前30天(±10天)常规测量的白蛋白水平低的儿科患者在移植后的重症监护干预措施风险较高。我们对接受同种异体HCT指示的小儿患者进行了为期5年的回顾性研究。根据白蛋白水平对患者进行分类。低白蛋白血症定义为<3.1 g / dL。总共纳入了73名患者,中位年龄为7.4岁(IQR 3.3,13.2)。低蛋白血症患者对重症监护干预措施的需求更高,包括无创通气(44%vs 8%,P = .01),机械通气(67%vs 17%,P <.01)和血管活性治疗(56%vs。 16%,P = .01)。低白蛋白血症患者的6个月死亡率也更高(56%比17%,P = .02)。我们的数据表明,在移植前期接受低蛋白血症的同种异体HCT的儿童更可能需要重症监护干预,并且6个月死亡率更高。这些发现确定了高危人群,他们可能在HCT之前进行营养改善,以期改善结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号